Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;81(2):e132-e135.
doi: 10.1016/j.jinf.2020.05.075. Epub 2020 Jun 3.

Does type of immunosupression influence the course of Covid-19 infection?

J Razanamahery  1 , T Soumagne  2 , S Humbert  3 , A S Brunel  4 , Q Lepiller  5 , E Daguindau  6 , L Mansi  7 , C Chirouze  8 , K Bouiller  4
Affiliations
Comment

Does type of immunosupression influence the course of Covid-19 infection?

J Razanamahery et al. J Infect. 2020 Aug.

Abstract

Coronavirus disease 19 (Covid-19) is a new emerging virus responsible for pandemic and death. High blood pressure, diabetes, obesity have been described as poor prognosis factors. Few data have been reported in patient with immunocompromised status (solid tumor, hematological malignancy, rheumatoid conditions or organ transplant). We evaluated the characteristics of patients, including the outcome, with immunodepression hospitalized in Besancon University hospital (East of France). We wanted to identify if a type of immunosupression influences the course of Covid-19. In a cohort of 80 patients with immunosupression (42 solid tumors, 20 hematological malignancy and 18 non neoplastic immunosupression), poor outcomes (Intensive care unit hospitalization and or deaths) was frequent (38%) and tended to be more frequent in patients with hematological malignancy.

Keywords: Covid-19; cancer; immunosupression; poor outcomes.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no competing financial interest and received no grants related to this study.

Comment on

References

    1. Chiara Minotti, Francesca Tirelli, Elisa Barbieri, Carlo Giaquinto, Daniele Donà. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infect. 2020 doi: 10.1016/j.jinf.2020.04.026. - DOI - PMC - PubMed
    1. Ya Gao, Yamin Chen, Ming Liu, Shuzhen Shi, Jinhui Tian. Impacts of immunosuppression and immunodeficiency on COVID-19: a systematic review and meta-analysis. J Infect. 2020 doi: 10.1016/j.jinf.2020.05.017. - DOI - PMC - PubMed
    1. Moore John B., June Carl H. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi: 10.1126/science.abb8925. - DOI - PubMed
    1. Jerome Hadjadj, Nader Yatim, Laura Barnabei, et al Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients. doi.org/10.1101/2020.04.19.20068015 - PMC - PubMed
    1. Reynolds Harmony R., Samrachana Adhikari, Claudia Pulgarin, Troxel Andrea B., Eduardo Iturrate, Johnson Stephen B. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2008975. - DOI - PMC - PubMed